BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perazella MA. Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol. 2009;4:461-469. [PMID: 19201920 DOI: 10.2215/cjn.06011108] [Cited by in Crossref: 178] [Cited by in F6Publishing: 64] [Article Influence: 14.8] [Reference Citation Analysis]
Number Citing Articles
1 Gok Oguz E, Kiykim A, Turgutalp K, Olmaz R, Ozhan O, Muslu N, Horoz M, Bardak S, Sungur MA. Lack of nephrotoxicity of gadopentetate dimeglumine-enhanced non-vascular MRI and MRI without contrast agent in patients at high-risk for acute kidney injury. Med Sci Monit 2013;19:942-8. [PMID: 24193150 DOI: 10.12659/MSM.889579] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
2 Do C, DeAguero J, Brearley A, Trejo X, Howard T, Escobar GP, Wagner B. Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution. Kidney360 2020;1:561-8. [PMID: 34423308 DOI: 10.34067/kid.0000272019] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 He D, Chatterjee A, Fan X, Wang S, Eggener S, Yousuf A, Antic T, Oto A, Karczmar GS. Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis. Invest Radiol 2018;53:609-15. [PMID: 29702525 DOI: 10.1097/RLI.0000000000000466] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
4 Tang J, Lobatto ME, Read JC, Mieszawska AJ, Fayad ZA, Mulder WJ. Nanomedical Theranostics in Cardiovascular Disease. Curr Cardiovasc Imaging Rep 2012;5:19-25. [PMID: 22308199 DOI: 10.1007/s12410-011-9120-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
5 Damasco JA, Ohulchanskyy TY, Mahajan S, Chen G, Singh A, Kutscher HL, Huang H, Turowski SG, Spernyak JA, Singh AK, Lovell JF, Seshadri M, Prasad PN. Excretable, ultrasmall hexagonal NaGdF4:Yb50% nanoparticles for bimodal imaging and radiosensitization. Cancer Nanotechnol 2021;12:4. [PMID: 33603920 DOI: 10.1186/s12645-021-00075-x] [Reference Citation Analysis]
6 Golnabi AH, Meaney PM, Geimer SD, Paulsen KD. 3-D Microwave Tomography Using the Soft Prior Regularization Technique: Evaluation in Anatomically Realistic MRI-Derived Numerical Breast Phantoms. IEEE Trans Biomed Eng 2019;66:2566-75. [PMID: 30629488 DOI: 10.1109/TBME.2019.2892303] [Cited by in Crossref: 13] [Article Influence: 6.5] [Reference Citation Analysis]
7 Jinzaki M, Kitagawa K, Tsai IC, Chan C, Yu W, Yong HS, Choi BW; ASCI CCT & CMR Guideline Working Group. ASCI 2010 contrast media guideline for cardiac imaging: a report of the Asian Society of Cardiovascular Imaging cardiac computed tomography and cardiac magnetic resonance imaging guideline working group. Int J Cardiovasc Imaging 2010;26:203-12. [PMID: 20931289 DOI: 10.1007/s10554-010-9691-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
8 Dadfar SM, Roemhild K, Drude NI, von Stillfried S, Knüchel R, Kiessling F, Lammers T. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications. Adv Drug Deliv Rev 2019;138:302-25. [PMID: 30639256 DOI: 10.1016/j.addr.2019.01.005] [Cited by in Crossref: 250] [Cited by in F6Publishing: 152] [Article Influence: 125.0] [Reference Citation Analysis]
9 Tian X, Li H, Jiang X, Xie J, Gore JC, Xu J. Evaluation and comparison of diffusion MR methods for measuring apparent transcytolemmal water exchange rate constant. J Magn Reson 2017;275:29-37. [PMID: 27960105 DOI: 10.1016/j.jmr.2016.11.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
10 Zhou Z, Lu ZR. Gadolinium-based contrast agents for magnetic resonance cancer imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013;5:1-18. [PMID: 23047730 DOI: 10.1002/wnan.1198] [Cited by in Crossref: 212] [Cited by in F6Publishing: 159] [Article Influence: 23.6] [Reference Citation Analysis]
11 Daldrup-Link HE, Theruvath AJ, Rashidi A, Iv M, Majzner RG, Spunt SL, Goodman S, Moseley M. How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol. Pediatr Radiol 2021. [PMID: 34046709 DOI: 10.1007/s00247-021-05098-5] [Reference Citation Analysis]
12 Abdel-Kader K, Patel PR, Kallen AJ, Sinkowitz-Cochran RL, Bolton WK, Unruh ML. Nephrogenic systemic fibrosis: a survey of nephrologists' perceptions and practices. Clin J Am Soc Nephrol 2010;5:964-71. [PMID: 20299369 DOI: 10.2215/CJN.00140110] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
13 Tansi FL, Rüger R, Kollmeier AM, Böhm C, Kontermann RE, Teichgraeber UK, Fahr A, Hilger I. A fast and effective determination of the biodistribution and subcellular localization of fluorescent immunoliposomes in freshly excised animal organs. BMC Biotechnol 2017;17:8. [PMID: 28100205 DOI: 10.1186/s12896-017-0327-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
14 Wang F, Takahashi K, Li H, Zu Z, Li K, Xu J, Harris RC, Takahashi T, Gore JC. Assessment of unilateral ureter obstruction with multi-parametric MRI. Magn Reson Med 2018;79:2216-27. [PMID: 28736875 DOI: 10.1002/mrm.26849] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
15 Pike D, Shiu YT, Cho YF, Le H, Somarathna M, Isayeva T, Guo L, Symons JD, Kevil CG, Totenhagen J, Lee T. The effect of endothelial nitric oxide synthase on the hemodynamics and wall mechanics in murine arteriovenous fistulas. Sci Rep 2019;9:4299. [PMID: 30862797 DOI: 10.1038/s41598-019-40683-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
16 Nguyen HV, Detappe A, Gallagher NM, Zhang H, Harvey P, Yan C, Mathieu C, Golder MR, Jiang Y, Ottaviani MF, Jasanoff A, Rajca A, Ghobrial I, Ghoroghchian PP, Johnson JA. Triply Loaded Nitroxide Brush-Arm Star Polymers Enable Metal-Free Millimetric Tumor Detection by Magnetic Resonance Imaging. ACS Nano 2018;12:11343-54. [PMID: 30387988 DOI: 10.1021/acsnano.8b06160] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
17 Kielstein JT, Schiffer M. [Nephrogenic systemic fibrosis: a rare disease with grave consequences]. Internist (Berl) 2010;51:39-44. [PMID: 20033388 DOI: 10.1007/s00108-009-2408-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
18 Morita K, Nakaura T, Yoneyama M, Nagayama Y, Kidoh M, Uetani H, Ikeda O, Yamashita Y, Hirai T. Non-contrast renal MRA using multi-shot gradient echo EPI at 3-T MRI. Eur Radiol 2021;31:5959-66. [PMID: 33475775 DOI: 10.1007/s00330-020-07653-4] [Reference Citation Analysis]
19 Bhargava V, Singh K, Meena P, Sanyal R. Nephrogenic systemic fibrosis: A frivolous entity. World J Nephrol 2021;10:29-36. [PMID: 34136369 DOI: 10.5527/wjn.v10.i3.29] [Reference Citation Analysis]
20 Penet MF, Mikhaylova M, Li C, Krishnamachary B, Glunde K, Pathak AP, Bhujwalla ZM. Applications of molecular MRI and optical imaging in cancer. Future Med Chem 2010;2:975-88. [PMID: 20634999 DOI: 10.4155/fmc.10.25] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
21 Muehe AM, Feng D, von Eyben R, Luna-Fineman S, Link MP, Muthig T, Huddleston AE, Neuwelt EA, Daldrup-Link HE. Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults. Invest Radiol 2016;51:221-7. [PMID: 26656202 DOI: 10.1097/RLI.0000000000000230] [Cited by in Crossref: 52] [Cited by in F6Publishing: 35] [Article Influence: 10.4] [Reference Citation Analysis]
22 Spasojević-Dimitrijeva B, Kotur-Stevuljević J, Đukić M, Paripović D, Miloševski-Lomić G, Spasojević-Kalimanovska V, Pavićević P, Mitrović J, Kostić M. Serum Neutrophil Gelatinase-Associated Lipocalin and Urinary Kidney Injury Molecule-1 as Potential Biomarkers of Subclinical Nephrotoxicity After Gadolinium-Based and Iodinated-Based Contrast Media Exposure in Pediatric Patients with Normal Kidney Function. Med Sci Monit 2017;23:4299-305. [PMID: 28874655 DOI: 10.12659/msm.903255] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
23 Freiman M, Voss SD, Mulkern RV, Perez-Rossello JM, Warfield SK. Quantitative body DW-MRI biomarkers uncertainty estimation using unscented wild-bootstrap. Med Image Comput Comput Assist Interv 2011;14:74-81. [PMID: 21995015 DOI: 10.1007/978-3-642-23629-7_10] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
24 Lingwood MD, Siaw TA, Sailasuta N, Ross BD, Bhattacharya P, Han S. Continuous flow Overhauser dynamic nuclear polarization of water in the fringe field of a clinical magnetic resonance imaging system for authentic image contrast. J Magn Reson 2010;205:247-54. [PMID: 20541445 DOI: 10.1016/j.jmr.2010.05.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
25 Ansari NA, Ramalho M, Semelka RC, Buonocore V, Gigli S, Maccioni F. Role of magnetic resonance imaging in the detection and characterization of solid pancreatic nodules: An update. World J Radiol 2015;7:361-74. [PMID: 26644822 DOI: 10.4329/wjr.v7.i11.361] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
26 Kim J, Lee N, Hyeon T. Recent development of nanoparticles for molecular imaging. Philos Trans A Math Phys Eng Sci 2017;375:20170022. [PMID: 29038377 DOI: 10.1098/rsta.2017.0022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 16.0] [Reference Citation Analysis]
27 Lartigue L, Coupeau M, Lesault M. Luminophore and Magnetic Multicore Nanoassemblies for Dual-Mode MRI and Fluorescence Imaging. Nanomaterials (Basel) 2019;10:E28. [PMID: 31861876 DOI: 10.3390/nano10010028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
28 Lameire N, Kellum JA; KDIGO AKI Guideline Work Group. Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2). Crit Care. 2013;17:205. [PMID: 23394215 DOI: 10.1186/cc11455] [Cited by in Crossref: 94] [Cited by in F6Publishing: 81] [Article Influence: 11.8] [Reference Citation Analysis]
29 Ozkok S, Ozkok A. Contrast-induced acute kidney injury: A review of practical points. World J Nephrol 2017;6:86-99. [PMID: 28540198 DOI: 10.5527/wjn.v6.i3.86] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 40] [Article Influence: 13.5] [Reference Citation Analysis]
30 Mehta AN, Fenves A. Current opinions in renovascular hypertension. Proc (Bayl Univ Med Cent) 2010;23:246-9. [PMID: 20671820 DOI: 10.1080/08998280.2010.11928627] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
31 Perera VS, Yang LD, Hao J, Chen G, Erokwu BO, Flask CA, Zavalij PY, Basilion JP, Huang SD. Biocompatible nanoparticles of KGd(H₂O)₂[Fe(CN)₆]·H₂O with extremely high T₁-weighted relaxivity owing to two water molecules directly bound to the Gd(III) center. Langmuir 2014;30:12018-26. [PMID: 25238130 DOI: 10.1021/la501985p] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
32 Lau JF, Weinberg MD, Olin JW. Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis. Nat Rev Cardiol 2011;8:405-18. [PMID: 21629211 DOI: 10.1038/nrcardio.2011.66] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
33 Siew EL, Farris AF, Rashid N, Chan KM, Rajab NF. In vitro toxicological assessment of gadolinium (III) chloride in V79-4 fibroblasts. Genes Environ 2020;42:22. [PMID: 32537035 DOI: 10.1186/s41021-020-00161-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Mora-Gutiérrez JM, Fernández-Seara MA, Echeverria-Chasco R, Garcia-Fernandez N. Perspectives on the Role of Magnetic Resonance Imaging (MRI) for Noninvasive Evaluation of Diabetic Kidney Disease. J Clin Med 2021;10:2461. [PMID: 34199385 DOI: 10.3390/jcm10112461] [Reference Citation Analysis]
35 Lingwood MD, Siaw TA, Sailasuta N, Abulseoud OA, Chan HR, Ross BD, Bhattacharya P, Han S. Hyperpolarized water as an MR imaging contrast agent: feasibility of in vivo imaging in a rat model. Radiology 2012;265:418-25. [PMID: 22996746 DOI: 10.1148/radiol.12111804] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
36 Sawhney S, Wilson SR. Can Ultrasound With Contrast Enhancement Replace Nonenhanced Computed Tomography Scans in Patients With Contraindication to Computed Tomography Contrast Agents? Ultrasound Q 2017;33:125-32. [PMID: 28141682 DOI: 10.1097/RUQ.0000000000000271] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 4.3] [Reference Citation Analysis]
37 Geppert M, Himly M. Iron Oxide Nanoparticles in Bioimaging - An Immune Perspective. Front Immunol 2021;12:688927. [PMID: 34211476 DOI: 10.3389/fimmu.2021.688927] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Han S, Yoon SH, Lee W, Choi YH, Kang DY, Kang HR. Management of Adverse Reactions to Iodinated Contrast Media for Computed Tomography in Korean Referral Hospitals: A Survey Investigation. Korean J Radiol 2019;20:148-57. [PMID: 30627030 DOI: 10.3348/kjr.2017.0771] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
39 Twombley K, Baum M, Gattineni J. Accidental and iatrogenic causes of acute kidney injury. Curr Opin Pediatr 2011;23:208-14. [PMID: 21293274 DOI: 10.1097/MOP.0b013e328343cd16] [Cited by in Crossref: 6] [Article Influence: 0.6] [Reference Citation Analysis]
40 van Gastel MDA, Messchendorp AL, Kappert P, Kaatee MA, de Jong M, Renken RJ, Ter Horst GJ, Mahesh SVK, Gansevoort RT; DIPAK Consortium. T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease. Abdom Radiol (NY) 2018;43:1215-22. [PMID: 28871393 DOI: 10.1007/s00261-017-1285-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
41 Schneider AG, Goodwin MD, Bellomo R. Measurement of kidney perfusion in critically ill patients. Crit Care 2013;17:220. [PMID: 23514525 DOI: 10.1186/cc12529] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
42 Hsu JC, Naha PC, Lau KC, Chhour P, Hastings R, Moon BF, Stein JM, Witschey WRT, McDonald ES, Maidment ADA, Cormode DP. An all-in-one nanoparticle (AION) contrast agent for breast cancer screening with DEM-CT-MRI-NIRF imaging. Nanoscale 2018;10:17236-48. [PMID: 30191237 DOI: 10.1039/c8nr03741h] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
43 Tenorio Jimenez C, Montalvo Valdivieso A, López Gallardo G, Mcgowan B. Pituitary involvement in Wegener's granulomatosis: unusual biochemical findings and severe malnutrition. BMJ Case Rep 2011;2011:bcr0220113850. [PMID: 22673710 DOI: 10.1136/bcr.02.2011.3850] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
44 Wallat JD, Czapar AE, Wang C, Wen AM, Wek KS, Yu X, Steinmetz NF, Pokorski JK. Optical and Magnetic Resonance Imaging Using Fluorous Colloidal Nanoparticles. Biomacromolecules 2017;18:103-12. [PMID: 27992176 DOI: 10.1021/acs.biomac.6b01389] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
45 Weems AC, Szafron JM, Easley AD, Herting S, Smolen J, Maitland DJ. Shape memory polymers with enhanced visibility for magnetic resonance- and X-ray imaging modalities. Acta Biomater 2017;54:45-57. [PMID: 28259837 DOI: 10.1016/j.actbio.2017.02.045] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
46 . Chapter 5: Referral to specialists and models of care. Kidney Int Suppl (2011) 2013;3:112-9. [PMID: 25599001 DOI: 10.1038/kisup.2012.68] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
47 Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA, Friedrich MG, Ho VB, Jerosch-Herold M, Kramer CM, Manning WJ, Patel M, Pohost GM, Stillman AE, White RD, Woodard PK; American College of Cardiology Foundation Task Force on Expert Consensus Documents. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation 2010;121:2462-508. [PMID: 20479157 DOI: 10.1161/CIR.0b013e3181d44a8f] [Cited by in Crossref: 221] [Cited by in F6Publishing: 67] [Article Influence: 20.1] [Reference Citation Analysis]
48 Muehe AM, Theruvath AJ, Lai L, Aghighi M, Quon A, Holdsworth SJ, Wang J, Luna-Fineman S, Marina N, Advani R, Rosenberg J, Daldrup-Link HE. How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford Approach. Mol Imaging Biol 2018;20:324-35. [PMID: 28721605 DOI: 10.1007/s11307-017-1105-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
49 Shinohara RT, Goldsmith J, Mateen FJ, Crainiceanu C, Reich DS. Predicting breakdown of the blood-brain barrier in multiple sclerosis without contrast agents. AJNR Am J Neuroradiol 2012;33:1586-90. [PMID: 22442041 DOI: 10.3174/ajnr.A2997] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
50 Kasper JY, Hermanns MI, Cavelius C, Kraegeloh A, Jung T, Danzebrink R, Unger RE, Kirkpatrick CJ. The role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified Caco-2 model including endothelial cells resembling the intestinal barrier in vitro. Int J Nanomedicine 2016;11:6353-64. [PMID: 27994454 DOI: 10.2147/IJN.S92608] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
51 Do C, Barnes JL, Tan C, Wagner B. Type of MRI contrast, tissue gadolinium, and fibrosis. Am J Physiol Renal Physiol 2014;307:F844-55. [PMID: 25100280 DOI: 10.1152/ajprenal.00379.2014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
52 Prabhakaran V, Nair VA, Austin BP, La C, Gallagher TA, Wu Y, McLaren DG, Xu G, Turski P, Rowley H. Current status and future perspectives of magnetic resonance high-field imaging: a summary. Neuroimaging Clin N Am 2012;22:373-97, xii. [PMID: 22548938 DOI: 10.1016/j.nic.2012.02.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
53 Shah AH, Olivero JJ. Gadolinium-Induced Nephrogenic Systemic Fibrosis. Methodist Debakey Cardiovasc J 2017;13:172-3. [PMID: 29744004 DOI: 10.14797/mdcj-13-3-172] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
54 . Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD. Kidney Int Suppl (2011) 2013;3:91-111. [PMID: 25599000 DOI: 10.1038/kisup.2012.67] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
55 . Section 4: Contrast-induced AKI. Kidney Int Suppl (2011) 2012;2:69-88. [PMID: 25018920 DOI: 10.1038/kisup.2011.34] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
56 Mawad H, Laurin LP, Naud JF, Leblond FA, Henley N, Vallée M, Pichette V, Leblanc M. Changes in Urinary and Serum Levels of Novel Biomarkers after Administration of Gadolinium-based Contrast Agents. Biomark Insights 2016;11:91-4. [PMID: 27398022 DOI: 10.4137/BMI.S39199] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
57 Nosrati H, Salehiabar M, Fridoni M, Abdollahifar MA, Kheiri Manjili H, Davaran S, Danafar H. New Insight about Biocompatibility and Biodegradability of Iron Oxide Magnetic Nanoparticles: Stereological and In Vivo MRI Monitor. Sci Rep 2019;9:7173. [PMID: 31073222 DOI: 10.1038/s41598-019-43650-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 13.5] [Reference Citation Analysis]
58 Lusic H, Grinstaff MW. X-ray-computed tomography contrast agents. Chem Rev. 2013;113:1641-1666. [PMID: 23210836 DOI: 10.1021/cr200358s] [Cited by in Crossref: 520] [Cited by in F6Publishing: 372] [Article Influence: 57.8] [Reference Citation Analysis]
59 Kwon C, Kang KM, Choi YH, Yoo RE, Sohn CH, Han SS, Yoon SH. Renal Safety of Repeated Intravascular Administrations of Iodinated or Gadolinium-Based Contrast Media within a Short Interval. Korean J Radiol 2021;22:1547-54. [PMID: 34132080 DOI: 10.3348/kjr.2020.1153] [Reference Citation Analysis]
60 Wray P, Lin L, Hu P, Wang LV. Photoacoustic computed tomography of human extremities. J Biomed Opt 2019;24:1-8. [PMID: 30784244 DOI: 10.1117/1.JBO.24.2.026003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 16.0] [Reference Citation Analysis]
61 Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA, Friedrich MG, Ho VB, Jerosch-Herold M, Kramer CM, Manning WJ, Patel M, Pohost GM, Stillman AE, White RD, Woodard PK; American College of Cardiology Foundation Task Force on Expert Consensus Documents. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 2010;55:2614-62. [PMID: 20513610 DOI: 10.1016/j.jacc.2009.11.011] [Cited by in Crossref: 411] [Cited by in F6Publishing: 286] [Article Influence: 37.4] [Reference Citation Analysis]
62 Penet MF, Artemov D, Farahani K, Bhujwalla ZM. MR - eyes for cancer: looking within an impenetrable disease. NMR Biomed 2013;26:745-55. [PMID: 23784955 DOI: 10.1002/nbm.2980] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
63 Tian M, Wen X, Jackson EF, Ng C, Uthamanthil R, Liang D, Gelovani JG, Li C. Pharmacokinetics and magnetic resonance imaging of biodegradable macromolecular blood-pool contrast agent PG-Gd in non-human primates: a pilot study. Contrast Media Mol Imaging 2011;6:289-97. [PMID: 21861289 DOI: 10.1002/cmmi.431] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
64 Mao X, Xu J, Cui H. Functional nanoparticles for magnetic resonance imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2016;8:814-41. [PMID: 27040463 DOI: 10.1002/wnan.1400] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]